Illumigyn

The company's core offering, the Gynoscope, is a compact, high-resolution imaging system that attaches to a standard speculum. It captures and illuminates the cervix, vagina, and vulva, allowing for detailed examination and documentation. A key feature of the system is its ability to upload captured images and data to a secure cloud platform. This enables physicians to remotely access patient information, consult with specialists, and utilize AI-based algorithms for diagnostic support. The system is designed to be operated by any trained healthcare professional, not just gynecologists, with the goal of expanding access to quality screening in various healthcare settings.

Illumigyn operates on a business-to-business model, supplying its Gynoscope systems to hospitals, clinics, and healthcare providers. Its revenue is likely generated from the sale of the devices and potentially through a subscription model for its cloud platform and associated services. The company targets the global women's health market, with a particular emphasis on improving early detection rates for cervical cancer and other pathologies. By providing a tool for more accessible and documented examinations, Illumigyn aims to standardize the quality of care and create a comprehensive database for future research and analysis. The company has secured CE marking for its product, allowing for its commercialization within the European market, and has established distribution agreements in various regions, including the Gulf countries, India, and Africa.